Accelerating drug development for Alzheimer's disease through the use of data standards

INTRODUCTION: The exceedingly high rate of failed trials in Alzheimer's disease (AD) calls for immediate attention to improve efficiencies and learning from past, ongoing, and future trials. Accurate, highly rigorous standardized data are at the core of meaningful scientific research. Data stan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (N Y)
Main Authors: Neville, Jon, Kopko, Steve, Romero, Klaus, Corrigan, Brian, Stafford, Bob, LeRoy, Elizabeth, Broadbent, Steve, Cisneroz, Martin, Wilson, Ethan, Reiman, Eric, Vanderstichele, Hugo, Arnerić, Stephen P., Stephenson, Diane
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Featured Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651436/
https://ncbi.nlm.nih.gov/pubmed/29067333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2017.03.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados